-
2024-514401-54-00
5
2025-11-13
Chronic Primary Immune Thrombocytopenia
-
2024-517411-73-00
6
2025-11-12
Patient with medium or high risk for pneumococcal invasive infection
-
2024-519871-24-00
10
2025-11-11
Breast cancer
-
2024-520190-12-00
5
2025-11-10
Breast Cancer: triple negative breast cancer (TNBC) and hormone recept
-
2025-520566-22-00
5
2025-11-10
Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Ca
-
2024-517316-29-00
4
2025-11-07
Unresectable stage III Non-Small Cell Lung Cancer
-
2025-522169-31-00
4
2025-10-30
Adult Patients with HER2-IHC3+ selected solid cancers (endometrial, co
-
2023-506843-40-00
5
2025-10-29
Mycobacterium xenopi pulmonary infection
-
2024-519917-72-00
5
2025-10-29
Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with C
-
2025-520694-39-00
4
2025-10-24
Metastatic or locally advanced irresectable (stage IV) gastric cancer
-
2024-514912-28-00
10
2025-10-22
Patients with hepatocellular carcinoma with high tumor burden.
-
2024-520413-53-00
5
2025-10-21
Spinocerebellar ataxia
-
2025-522656-68-00
6
2025-10-15
Metastatic breast cancers
-
2023-509728-16-00
4
2025-10-10
advanced Parkinson’s disease
-
2024-516652-18-00
5
2025-10-10
Atherosclerotic cardiovascular disease (ASCVD) and obesity or overweig
-
2025-521147-21-00
4
2025-10-08
Lung Cancer
-
2024-519188-17-00
1
2025-10-07
Relapsed/refractory malignancy with documented diagnosis of human epid
-
2024-518358-17-00
4
2025-10-06
Squamous cell carcinoma of the esophagus
-
2024-515249-41-00
10
2025-10-01
Cardiorespiratory arrest at birth in full-term newborns
-
2024-517671-21-00
5
2025-09-30
Coronavirus Disease 2019 (COVID-19)
-
2024-518296-56-00
5
2025-09-29
Crohn’s Disease
-
2024-511989-36-00
5
2025-09-24
Ewing Sarcoma
-
2024-520386-31-00
5
2025-09-22
Locally Advanced Head & Neck Squamous Cell Carcinoma
-
2024-517780-24-00
5
2025-09-18
Lung Cancer